主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
MLTX
#2020
MoonLake Immunotherapeutics Class A Ordinary Shares
17.510
0
-0.68%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.68%
每月变动
+7.49%
6个月变化
+83.16%
年变化
+83.16%
前一天收盘价
17.630
0
Open
17.510
0
Bid
Ask
Low
17.510
0
High
17.510
0
交易量
76
市场
股票
医疗保健
MLTX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
MoonLake hisseleri pozitif axSpA deneme verileriyle yükseldi
MoonLake stock surges on positive axSpA trial data
MoonLake hissesi InvestingPro Gerçeğe Uygun Değer çağrısı sonrası %63 yükseldi
MoonLake stock surges 63% after InvestingPro Fair Value call
MoonLake aksiyel spondiloartrit için olumlu faz 2 verisi açıkladı
MoonLake reports positive phase 2 axial spondyloarthritis data
ImageneBio, Dr. Porter-Brown’ı Tıbbi Direktör olarak atadı
ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer
BTIG, Moonlake Immunotherapeutics hissesi için veri öncesi Al notunu yineliyor